Mindblown: a blog about philosophy.
Factbox-What is the humanitarian situation in besieged Gaza?
GENEVA (Reuters) -Only a trickle of humanitarian aid is being allowed to enter besieged Gaza as Israel forces press on with their military campaign in response to Hamas’ deadly Oct. 7 attack on southern Israel. U.N. agencies and the Red Cross have warned of a “humanitarian disaster” enveloping the tiny Hamas-controlled enclave of 2.3 million […]
Factbox-What is the humanitarian situation in besieged Gaza?
GENEVA (Reuters) -Only a trickle of humanitarian aid is being allowed to enter besieged Gaza as Israel forces press on with their military campaign in response to Hamas’ deadly Oct. 7 attack on southern Israel. U.N. agencies and the Red Cross have warned of a “humanitarian disaster” enveloping the tiny Hamas-controlled enclave of 2.3 million […]
Factbox-What is the humanitarian situation in besieged Gaza?
GENEVA (Reuters) -Only a trickle of humanitarian aid is being allowed to enter besieged Gaza as Israel forces press on with their military campaign in response to Hamas’ deadly Oct. 7 attack on southern Israel. U.N. agencies and the Red Cross have warned of a “humanitarian disaster” enveloping the tiny Hamas-controlled enclave of 2.3 million […]
Earnings call: Harrow reports record revenues, anticipates continued growth despite challenges
Harrow’s Third Quarter 2023 Earnings Conference Call revealed record revenues and improved adjusted gross margins, despite experiencing a non-linear growth trajectory and challenges in meeting internal development timelines. The company reported a decrease in earnings of $36 million to $41 million due to lower revenue estimates and increased costs from recent acquisitions, among other factors. […]
Earnings call: DURECT reports Q3 2023 financial results, positive clinical trial results
DURECT Corporation (NASDAQ:DRRX) announced its financial results for the third quarter of 2023, reporting total revenues of $1.7 million. This figure is a significant decrease from the $12 million reported in the same period last year, primarily due to the recognition of milestone revenue in 2022. The company also revealed positive results from its AHFIRM […]
Factbox-What is the humanitarian situation in besieged Gaza?
GENEVA (Reuters) -Only a trickle of humanitarian aid is being allowed to enter besieged Gaza as Israel forces press on with their military campaign in response to Hamas’ deadly Oct. 7 attack on southern Israel. U.N. agencies and the Red Cross have warned of a “humanitarian disaster” enveloping the tiny Hamas-controlled enclave of 2.3 million […]
Earnings call: Harrow reports record revenues, anticipates continued growth despite challenges
Harrow’s Third Quarter 2023 Earnings Conference Call revealed record revenues and improved adjusted gross margins, despite experiencing a non-linear growth trajectory and challenges in meeting internal development timelines. The company reported a decrease in earnings of $36 million to $41 million due to lower revenue estimates and increased costs from recent acquisitions, among other factors. […]
Earnings call: DURECT reports Q3 2023 financial results, positive clinical trial results
DURECT Corporation (NASDAQ:DRRX) announced its financial results for the third quarter of 2023, reporting total revenues of $1.7 million. This figure is a significant decrease from the $12 million reported in the same period last year, primarily due to the recognition of milestone revenue in 2022. The company also revealed positive results from its AHFIRM […]
Factbox-What is the humanitarian situation in besieged Gaza?
GENEVA (Reuters) -Only a trickle of humanitarian aid is being allowed to enter besieged Gaza as Israel forces press on with their military campaign in response to Hamas’ deadly Oct. 7 attack on southern Israel. U.N. agencies and the Red Cross have warned of a “humanitarian disaster” enveloping the tiny Hamas-controlled enclave of 2.3 million […]
Earnings call: Pulse Biosciences showcases progress in Q3 2023, eyes cardiac ablation market with CellFX nsPFA technology
Pulse Biosciences (NASDAQ:PLSE) reported significant advancements in their CellFX nsPFA technology during their Q3 2023 earnings call. The company emphasized its progress in the treatment of atrial fibrillation and benign thyroid nodules and highlighted the appointment of Dr. Niv Ad as Chief Science Officer, Cardiac Surgery. The company is on track with the development of […]
Got any book recommendations?